Clinical trial sa paghahalo sa AstraZeneca at Sputnik V, aprub sa Russia

ni Ronalyn Seminiano Reonico | July 27, 2021

Inaprubahan na ng Russia ang pagsasagawa ng clinical trials para sa pinaghalong AstraZeneca at Sputnik V COVID-19 vaccines.

Noong Mayo, sinuspinde ng health ministry ng Russia ang pagsisimula ng pagsasagawa ng clinical trials para sa mga naturang bakuna ngunit matapos ang ilang pag-aaral ay itinuloy na ito.

Ayon sa awtoridad, limang Russian clinics ang magsasagawa ng naturang clinical trials at inaasahang matatapos ito sa Mayo, 2022.

Pahayag pa ng Russian Direct Investment Fund (RDIF), "Currently, RDIF is conducting joint clinical trials to combine the first component of Sputnik V - the Sputnik Light vaccine - with vaccines from other foreign manufacturers.

"In particular, the Sputnik Light vaccine can be used in combination with other vaccine to increase their effectiveness including against new variants appearing as a result of the mutation of the virus."